Correlation Between Oncolytics Biotech and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and Lyra Therapeutics, you can compare the effects of market volatilities on Oncolytics Biotech and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Lyra Therapeutics.
Diversification Opportunities for Oncolytics Biotech and Lyra Therapeutics
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Oncolytics and Lyra is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Oncolytics Biotech and Lyra Therapeutics
Given the investment horizon of 90 days Oncolytics Biotech is expected to under-perform the Lyra Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 2.49 times less risky than Lyra Therapeutics. The stock trades about -0.34 of its potential returns per unit of risk. The Lyra Therapeutics is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest 25.00 in Lyra Therapeutics on August 28, 2024 and sell it today you would lose (6.00) from holding Lyra Therapeutics or give up 24.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncolytics Biotech vs. Lyra Therapeutics
Performance |
| Timeline |
| Oncolytics Biotech |
| Lyra Therapeutics |
Oncolytics Biotech and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncolytics Biotech and Lyra Therapeutics
The main advantage of trading using opposite Oncolytics Biotech and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |